Research boost to improve outcomes for melanoma patients
11 October 2017
More than $3.5 million in competitive funding grants have been awarded to researchers at Melanoma Institute Australia as part of the National Health and Medical Research Council’s (NHMRC) funding outcomes, announced today.
In partnership with The University of Sydney, the boost will support a Practitioner Fellowship, a Career Development Fellowship and a Centre of Research Excellence aimed at driving better outcomes in melanoma.
MIA’s Co-Medical Director, Professor Richard Scolyer, was awarded a Practitioner Fellowship that will aim to utilise the extensive resources at MIA to improve outcomes of patients with difficult and aggressive melanomas.
Epidemiologist Associate Professor Anne Cust received a Career Development Fellowship for her research into skin cancer epidemiology, prevention and screening that will lead to improved patient and population health through impacting clinical practice and health policy.
Chair of MIA’s Research Committee Professor Graham Mann was awarded the Centre of Research Excellence in Melanoma grant. The project will identify the best way to conduct surveillance of high-risk melanoma patients, how to manage a person with melanoma who has a high potential for relapse, and how best to improve support, survivorship and the patient experience.
The funding will help facilitate MIA’s world-leading researchers to continue their ground-breaking work in melanoma research in order to improve outcomes for patients and their families.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play
This week, Melanoma Institute Australia hosted the first of six
Federal government urged
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.